[Federal Register Volume 86, Number 163 (Thursday, August 26, 2021)]
[Notices]
[Pages 47644-47645]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-18453]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2021-0089]


Advisory Committee on Immunization Practices (ACIP); Amended 
Notice of Meeting

AGENCY: Centers for Disease Control and Prevention, Department of 
Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC), announces the 
following meeting of the Advisory Committee on Immunization Practices 
(ACIP). This meeting is open to the public. Time will be available for 
public comment. The meeting will be webcast live via the World Wide 
Web; for more information on ACIP please visit the ACIP website: http://www.cdc.gov/vaccines/acip/index.html.

DATES: The meeting will be held on August 30, 2021 and August 31, 2021, 
from 10:00 a.m. to 4:00 p.m., EDT (times subject to change). The docket 
is currently open to receive written comments. Written comments must be 
received on or before August 31, 2021.
    A notice of this ACIP meeting has also been posted on CDC's ACIP 
website at: http://www.cdc.gov/vaccines/acip/index.html. In addition, 
CDC has sent notice of this ACIP meeting by email to those who 
subscribe to receive email updates about ACIP.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0089 by any of the following methods:

[[Page 47645]]

     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: Centers for Disease Control and Prevention, 1600 
Clifton Road NE, MS H24-8, Atlanta, Georgia 30329-4027, Attn: August 
30-31, 2021 ACIP Meeting.
    Instructions: All submissions received must include the Agency name 
and Docket Number. All relevant comments received in conformance with 
the https://www.regulations.gov suitability policy will be posted 
without change to https://www.regulations.gov, including any personal 
information provided. For access to the docket to read background 
documents or comments received, go to https://www.regulations.gov.

FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee 
Management Specialist, Centers for Disease Control and Prevention, 
National Center for Immunization and Respiratory Diseases, 1600 Clifton 
Road NE, MS-H24-8, Atlanta, GA 30329-4027; Telephone: 404-639-8367; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: Notice is hereby given of a change in the 
meeting of the Advisory Committee on Immunization Practices (ACIP); 
August 24, 2021, 10:00 a.m.-5:00 p.m., EDT (times subject to change), 
in the original FRN.
    The virtual meeting was published in the Federal Register on 
Wednesday, August 18, 2021, Volume 86, Number 157, pages 46256-46257.
    The virtual meeting is being amended to change the dates to August 
30, 2021 and August 31, 2021, update meeting times and supplemental 
information.
    In accordance with 41 CFR 102-3.150(b), less than 15 calendar days' 
notice is being given for this meeting due to the exceptional 
circumstances of the COVID-19 pandemic and rapidly evolving COVID-19 
vaccine development and regulatory processes. A notice of this ACIP 
meeting has also been posted on CDC's ACIP website at: http://www.cdc.gov/vaccines/acip/index.html. In addition, CDC has sent notice 
of this ACIP meeting by email to those who subscribe to receive email 
updates about ACIP.
    Purpose: The committee is charged with advising the Director, CDC, 
on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, 
the committee is mandated to establish and periodically review and, as 
appropriate, revise the list of vaccines for administration to vaccine-
eligible children through the Vaccines for Children (VFC) program, 
along with schedules regarding dosing interval, dosage, and 
contraindications to administration of vaccines. Further, under 
provisions of the Affordable Care Act, section 2713 of the Public 
Health Service Act, immunization recommendations of the ACIP that have 
been approved by the Director of the Centers for Disease Control and 
Prevention and appear on CDC immunization schedules must be covered by 
applicable health plans.
    Matters To Be Considered: The agenda will include discussions on 
Pfizer's COVID-19 vaccine, and additional discussions on mRNA booster 
doses. A recommendation vote on Pfizer's COVID-19 vaccine is planned. 
No Vaccines for Children (VFC) votes are scheduled. Agenda items are 
subject to change as priorities dictate. For more information on the 
meeting agenda visit https://www.cdc.gov/vaccines/acip/meetings/meetings-info.html.
    Meeting Information: The meeting will be webcast live via the World 
Wide Web; for more information on ACIP please visit the ACIP website: 
http://www.cdc.gov/vaccines/acip/index.html.

Public Participation

    Interested persons or organizations are invited to participate by 
submitting written views, recommendations, and data. Please note that 
comments received, including attachments and other supporting 
materials, are part of the public record and are subject to public 
disclosure. Comments will be posted on https://www.regulations.gov. 
Therefore, do not include any information in your comment or supporting 
materials that you consider confidential or inappropriate for public 
disclosure. If you include your name, contact information, or other 
information that identifies you in the body of your comments, that 
information will be on public display. CDC will review all submissions 
and may choose to redact, or withhold, submissions containing private 
or proprietary information such as Social Security numbers, medical 
information, inappropriate language, or duplicate/near duplicate 
examples of a mass-mail campaign. CDC will carefully consider all 
comments submitted into the docket.
    Oral Public Comment: This meeting will include time for members of 
the public to make an oral comment. Oral public comment will occur 
before any scheduled votes including all votes relevant to the ACIP's 
Affordable Care Act and Vaccines for Children Program roles. Priority 
will be given to individuals who submit a request to make an oral 
public comment before the meeting according to the procedures below.
    Procedure for Oral Public Comment: All persons interested in making 
an oral public comment at the August 30, 2021, ACIP meeting must submit 
a request at http://www.cdc.gov/vaccines/acip/meetings/ no later than 
11:59 p.m., EDT, August 28, 2021, according to the instructions 
provided.
    If the number of persons requesting to speak is greater than can be 
reasonably accommodated during the scheduled time, CDC will conduct a 
lottery to determine the speakers for the scheduled public comment 
session. CDC staff will notify individuals regarding their request to 
speak by email by August 29, 2021. To accommodate the significant 
interest in participation in the oral public comment session of ACIP 
meetings, each speaker will be limited to 3 minutes, and each speaker 
may only speak once per meeting.
    Written Public Comment: The docket is currently open to receive 
written comments. Written comments must be received on or before August 
31, 2021.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-18453 Filed 8-24-21; 11:15 am]
BILLING CODE 4163-18-P